Zobrazeno 1 - 10
of 64
pro vyhledávání: '"T. K. Daneshmend"'
Autor:
T K, Daneshmend, J D, Davies
Publikováno v:
Bristol Medico-Chirurgical Journal
We report a case of phenytoin-associated Hodgkin's disease of lymphocyte predominance subtype, which developed after two years of phenytoin (Epanutin) treatment. Four other English cases of phenytoin-associated lmphoid malignancy are also reviewed.
Autor:
T. K. Daneshmend, R. G. Long, M. Collins, R. P. Walt, Christopher J. Hawkey, B. T. Cooper, Michael J.S. Langman, R. F. A. Logan, R. Street
Publikováno v:
Alimentary Pharmacology & Therapeutics. 5:301-307
SUMMARY Roxatidine acetate is a new histamine H2-antagonist of about twice the potency of ranitidine on a weight-for-weight basis. Two hundred and thirty-two patients participated in a double-blind randomized trial of duodenal ulcer healing comparing
Autor:
T. K. Daneshmend, C. Malkinson, S. J. Everitt, A. B. Hawthorne, Andrea Belluzzi, M. Z. Shaheen, G. K. T. Holmes, Christopher J. Hawkey, J. E. Willars
Publikováno v:
Gut. 33:922-928
The effect of fish oil on the course of ulcerative colitis was investigated in a randomised blinded controlled study. Eighty seven patients received supplements of 20 ml HiEPA fish oil as triglyceride (4.5 g of eicosapentaenoic acid) or olive oil pla
Autor:
Michael J.S. Langman, Christopher J. Hawkey, T. K. Daneshmend, R. P. Walt, R. F. A. Logan, R. G. Long
Publikováno v:
BMJ. 304:143-147
OBJECTIVE--To investigate the possible therapeutic role of omeprazole, a powerful proton pump inhibitor, in unselected patients presenting with upper gastrointestinal bleeding. DESIGN--Double blind placebo controlled parallel group study. Active trea
Autor:
Christopher J. Hawkey, A. B. Hawthorne, N. Hudson, A. T. Cole, Yashwant R. Mahida, T. K. Daneshmend
Publikováno v:
Clinical Science. 81:565-573
1. An increasing body of data suggests that the anti-haemostatic as well as the ulcerogenic actions of aspirin and other non-steroidal anti-inflammatory drugs may be operative when patients present with haematemesis and melaena. 2. We therefore devel
Publikováno v:
BMJ. 300:986-990
OBJECTIVE--To evaluate the medical impact of reactive pharmacy intervention. DESIGN--Analysis of all interventions during 28 days by all 35 pharmacists in hospitals in Nottingham. SETTING--All (six) hospitals in the Nottingham health authority (a tea
Publikováno v:
Gut. 62:A73.2-A74
Introduction Recent meta-analyses of population based IBD mortality studies have shown no increase in standardised mortality ratio for ulcerative colitis (UC) 1 , but a small increase for Crohn’s disease (CD) 2 . 26–50% of deaths in CD patients w
Autor:
K So, C Bewshea, G A Heap, A F Muller, T K Daneshmend, A L Hart, T R Orchard, P M Irving, R K Russell, D C Wilson, M Parkes, J Satsangi, C W Lees, T Ahmad
Publikováno v:
Gut. 62:A22.1-A22
OBJECTIVE--To assess the cost effectiveness of screening for and eradicating Helicobacter pylori in patients under 45 years of age presenting with dyspepsia. DESIGN--A decision analytic model composed of a decision tree to represent the epidemiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::f54bfe4f88a66252b266fb4de49e7df3
https://europepmc.org/articles/PMC2352015/
https://europepmc.org/articles/PMC2352015/
Publikováno v:
Gut. 60:A215-A215
Introduction Infliximab (IFX) has been shown to be efficacious in the treatment of steroid refractory acute severe ulcerative colitis (ASUC) with reduced rates of colectomy at index admission and at 3-year follow-up. Previous studies from tertiary re